New study shows promise for diphenyl ditelluride as anti-cancer drug

FHS
June 27, 2023
2:00 am

A new research paper was published in Oncotarget’s Volume 14 on June 21, 2023, entitled, “Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells.”

Majority of patients with reflux disease do not have higher risk of cancer, study reports

Reflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer.

September 13, 2023

Blood Test May Be Able to Tell Which Organs Have Accelerated Aging

About one in five healthy people ages 50 and older had an organ that was aging at an accelerated rate, which may increase mortality and

December 7, 2023

EC grants orphan medicinal status for Rocket’s RP-A601

The gene therapy is currently under investigation as a one-time curative treatment. Credit: R Photography Background / Shutterstock.com. The European Commission (EC) has granted orphan

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.